☰

Subhodeep Sarker, Ph.D. - Publications

Affiliations: 
University of Sydney, Camperdown, New South Wales, Australia 
Area:
Molecular Pharmacology and Toxicology, Experimental Therapeutics
Website:
https://sites.google.com/site/subhodeepsarker1/
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mostyn SN, Sarker S, Muthuraman P, Raja A, Shimmon S, Rawling T, Cioffi CL, Vandenberg RJ. A photoswitchable ORG25543 congener enables optical control of glycine transporter 2. Acs Chemical Neuroscience. PMID 32191428 DOI: 10.1021/Acschemneuro.9B00655  0.646
2019 Mostyn SN, Rawling T, Mohammadi S, Shimmon S, Frangos ZJ, Sarker S, Yousuf A, Vetter I, Ryan RM, Christie MJ, Vandenberg RJ. Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain. Journal of Medicinal Chemistry. 62: 2466-2484. PMID 30714733 DOI: 10.1021/acs.jmedchem.8b01775  0.621
2019 Mostyn SN, Rawling T, Mohammadi S, Shimmon S, Frangos ZJ, Sarker S, Yousuf A, Vetter I, Ryan RM, Christie MJ, Vandenberg RJ. Development of an N-acyl amino acid that selectively inhibits the glycine transporter 2 to produce analgesia in a rat model of chronic pain. Journal of Medicinal Chemistry. PMID 30714733 DOI: 10.1021/Acs.Jmedchem.8B01775  0.647
2017 Sarker S, Menanteau-Ledouble S, Kotob MH, El-Matbouli M. A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo. Plos One. 12: e0178687. PMID 28575083 DOI: 10.1371/Journal.Pone.0178687  0.492
2015 Sarker S, El-Matbouli M. Can RNAi Target Salmonid Whirling Disease In Vivo? Nucleic Acid Therapeutics. 25: 285-6. PMID 26237296 DOI: 10.1089/nat.2015.0549  0.435
2015 Sarker S, Kallert DM, Hedrick RP, El-Matbouli M. Whirling disease revisited: pathogenesis, parasite biology and disease intervention. Diseases of Aquatic Organisms. 114: 155-75. PMID 25993890 DOI: 10.3354/Dao02856  0.485
2015 Hasenhuetl PS, Schicker K, Koenig X, Li Y, Sarker S, Stockner T, Sucic S, Sitte HH, Freissmuth M, Sandtner W. Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction. Molecular Pharmacology. 88: 12-8. PMID 25873594 DOI: 10.1124/Mol.115.099036  0.67
2015 Kumar G, Sarker S, Menanteau-Ledouble S, El-Matbouli M. Tetracapsuloides bryosalmonae infection affects the expression of genes involved in cellular signal transduction and iron metabolism in the kidney of the brown trout Salmo trutta. Parasitology Research. 114: 2301-8. PMID 25786607 DOI: 10.1007/S00436-015-4425-Z  0.509
2011 Sarker S, Xiao K, Shenoy SK. A tale of two sites: How ubiquitination of a G protein-coupled receptor is coupled to its lysosomal trafficking from distinct receptor domains. Communicative & Integrative Biology. 4: 528-31. PMID 22046454 DOI: 10.4161/Cib.4.5.16458  0.677
2011 Sucic S, El-Kasaby A, Kudlacek O, Sarker S, Sitte HH, Marin P, Freissmuth M. The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. The Journal of Biological Chemistry. 286: 16482-90. PMID 21454670 DOI: 10.1074/Jbc.M111.230037  0.664
2011 Sarker S, Xiao K, Shenoy SK. A Tale of Two Sites – How ubiquitination of a G protein-coupled receptor is coupled to its lysosomal trafficking from distinct receptor domains: How ubiquitination of a G protein-coupled receptor is coupled to its lysosomal trafficking from distinct receptor domains Communicative & Integrative Biology. 4: 528-531. DOI: 10.4161/Cib.16458  0.675
2011 Sucic S, Kern C, Vidovic D, Sarker S, Kudlacek O, Sitte HH, Freissmuth M. Truncations in the amino terminus reveal a region key to supporting amphetamine-induced efflux by the human serotonin transporter Bmc Pharmacology. 11: A20. DOI: 10.1186/1471-2210-11-S2-A20  0.659
2010 Sarker S, Weissensteiner R, Steiner I, Sitte HH, Ecker GF, Freissmuth M, Sucic S. The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Molecular Pharmacology. 78: 1026-35. PMID 20829432 DOI: 10.1124/Mol.110.067538  0.702
2010 Sucic S, El-Kasaby A, Sarker S, Sitte HH, Marin P, Freissmuth M. Concentrative ER export of the serotonin transporter relies exclusively on an interaction with Sec24C Bmc Pharmacology. 10. DOI: 10.1186/1471-2210-10-S1-A11  0.689
2008 Sarker S, Steiner I. Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter? Bmc Pharmacology. 8. DOI: 10.1186/1471-2210-8-S1-A9  0.45
2008 Elkasaby A, Sarker S, Just H. C-terminal mutation induces a folding defect in the serotonin transporter Bmc Pharmacology. 8: A7. DOI: 10.1186/1471-2210-8-S1-A7  0.421
Show low-probability matches.